OOIR: Observatory of International Research

Papers

(The TQCC of Substance Abuse Treatment Prevention and Policy is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users	60
The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public hea	52
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada	35
Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre	32
Validity of self-reported substance use: research setting versus primary health care setting	30
‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America	30
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review	28
Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study	27
Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study	26
Examining prevalence and correlates of smoking opioids in British Columbia: opioids are more often smoked than injected	26
20 years of Portuguese drug policy - developments, challenges and the quest for human rights	23
Patient perspectives on depot buprenorphine treatment for opioid addiction – a qualitative interview study	21
Strategies to promote the implementation of Screening, Brief Intervention, and Referral to Treatment (SBIRT) in healthcare settings: a scoping review	21
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway	21
A double-edged sword of using opioids and COVID-19: a toxicological view	20
The changing alcohol drinking patterns among older adults show that women are closing the gender gap in more frequent drinking: the Tromsø study, 1994–2016	20
A scoping review of factors that influence opioid overdose prevention for justice-involved populations	19
Implementation of tobacco control measures in the Gulf Cooperation Council countries, 2008–2020	19
Research led by people who use drugs: centering the expertise of lived experience	19
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs	19
Assessing the impact of a restrictive opioid prescribing law in West Virginia	18
Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review	18
Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada	18
Missed opportunity for alcohol use disorder screening and management in primary health care facilities in northern rural Tanzania: a cross-sectional survey	18
Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients	17

Frequencies of emergency department use and hospitalization comparing patients with different types of substance or polysubstance-related disorders	17
Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia	17
The relationship between family intimacy and relapse tendency among people who use drugs: a moderated mediation model	16
Gender disparities in opioid treatment progress in methadone versus counseling	16
Drug Abstinence Self-Efficacy Scale (DASES): psychometric properties of the Farsi version	16
Prevalence and associated factors for alcohol use disorder among tuberculosis patients: a systematic review and meta-analysis study	15
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study	15
Digital interventions for substance use disorders in young people: rapid review	15
Social capital and chemsex initiation in young gay, bisexual, and other men who have sex with men: the pink carpet Y cohort study	14
“The DEA would come in and destroy you”: a qualitative study of fear and unintended consequences among opioid prescribers in WV	14
Resilience and related factors as predictors of relapse risk in patients with substance use disorder: a cross-sectional study	13
Differences in addiction and recovery gains according to gender – gender barriers and specific differences in overall strengths growth	13
Naloxone availability in independent community pharmacies in Georgia, 2019	12
A qualitative study exploring how young people perceive and experience substance use services in British Columbia, Canada	12
Associations between parental alcohol problems in childhood and adversities during childhood and later adulthood: a cross-sectional study of 28047 adults from the general population	12
The growth of recovery capital in clients of recovery residences in Florida, USA: a quantitative pilot study of changes in REC-CAP profile scores	12
Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA	12
Concerns among people who use opioids during the COVID-19 pandemic: a natural language processing analysis of social media posts	11
The effects of maternal alcohol consumption during pregnancy on adverse fetal outcomes among pregnant women attending antenatal care at public health facilities in Gondar town, Northwest Ethiopia: a p	11
Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder	11
A review of research-supported group treatments for drug use disorders	11
Understanding injecting drug use in Afghanistan: A scoping review	10
Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes	10
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review	10
Various forms of alcohol use and their predictors among pregnant women in post conflict northern Uganda: a cross sectional study	10
Prevalence and correlates of substance use among school-going adolescents (11-18years) in eight Sub-Saharan Africa countries	10
Prevalence and correlates of non-daily and daily cannabis use among persons 15 years and older in South Africa: results of a national survey in 2017	10
Factors associated with substance use disorder treatment completion: a cross-sectional analysis of justice-involved adolescents	10
Cyber-ethnography of cannabis marketing on social media	10
Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators	10
Qualitative assessment of patients’ perspectives and needs from community pharmacists in substance use disorder management	9
Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021	9
The association between methamphetamine use and number of sexual partners in men who have sex with men: a systematic review and meta-analysis	9
Perspectives of illicit marijuana growers and traders on commercial legalisation of marijuana in South Africa: considerations for policy formulation	9
Youth substance use service provider’s perspectives on use and service access in ontario: time to reframe the discourse	9
“They’re not doing enough.”: women’s experiences with opioids and naloxone in Toronto	9
Tobacco use, smoking identities and pathways into and out of smoking among young adults: a meta-ethnography	8
COVID 19—impact on substance use treatment utilization and provision in South Africa	8
The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence	8
Alcohol use and associated factors among adolescent boys and young men in Kampala, Uganda	8
The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men	8
Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: a repeated cross-sectional study from May 2020 to December 2020	8
“I can’t live like that”: the experience of caregiver stress of caring for a relative with substance use disorder	8
Relationships between consumption patterns, health beliefs, and subjective wellbeing in Chinese Baijiu consumers	8
Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy	8
Changes in opioid-related deaths following increased access to opioid substitution treatment	8
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020	8
The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis	7
Effects of treatment status and life quality on anxiety in MMT patients	7
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment	7

Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals’ experiences	7
Becoming our young people’s case managers: caregivers’ experiences, needs, and ideas for improving opioid use treatments for young people using opioids	7
“That’s the whole thing about vaping, it’s custom tasty goodness”: a meta-ethnography of young adults’ perceptions and experiences of e-cigarette use	7
Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study	7
School-based harm reduction with adolescents: a pilot study	7
Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs	7
Alcohol and illicit drug use among young people living with HIV compared to their uninfected peers from the Kenyan coast: prevalence and risk indicators	7
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study	7
The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya	7
Polysubstance use in a community sample of Black cisgender sexual minority men and transgender women in Chicago during initial COVID-19 pandemic peak	7